Nizam, A.; Bustamante, B.; Shan, W.; Shih, K.K.; Whyte, J.S.; Sakaris, A.; dos Santos, L.; Frimer, M.; Menzin, A.W.; Truskinovsky, A.;
et al. Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience. Diagnostics 2019, 9, 200.
https://doi.org/10.3390/diagnostics9040200
AMA Style
Nizam A, Bustamante B, Shan W, Shih KK, Whyte JS, Sakaris A, dos Santos L, Frimer M, Menzin AW, Truskinovsky A,
et al. Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience. Diagnostics. 2019; 9(4):200.
https://doi.org/10.3390/diagnostics9040200
Chicago/Turabian Style
Nizam, Aaron, Bethany Bustamante, Weiwei Shan, Karin K. Shih, Jill S. Whyte, Antoinette Sakaris, Lisa dos Santos, Marina Frimer, Andrew W. Menzin, Alexander Truskinovsky,
and et al. 2019. "Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience" Diagnostics 9, no. 4: 200.
https://doi.org/10.3390/diagnostics9040200
APA Style
Nizam, A., Bustamante, B., Shan, W., Shih, K. K., Whyte, J. S., Sakaris, A., dos Santos, L., Frimer, M., Menzin, A. W., Truskinovsky, A., & Goldberg, G. L.
(2019). Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience. Diagnostics, 9(4), 200.
https://doi.org/10.3390/diagnostics9040200
